19 Apr 2025, Sat

Breaking

China pushes anti-‘bullying’ agenda amid tensions with US

DOGE, CFPB disregarded court orders in mass firings, statement says

Factbox-Citi raises three-month gold price target to $3,500 per ounce

Trump administration kicks off plan for expanded offshore drilling

Apple CEO spoke with Lutnick about tariff impact on iPhone prices, Washington Post says

N2:HEA

N2:ACB N2:CMPNY N2:DEAL1 N2:EUROP N2:HEA N2:IE N2:INSR N2:JUDIC N2:MONOP N2:MRG N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PHMR N2:PUBL N2:REGS N2:US N2:WASH

US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics

(Reuters) -The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen’s $27.8 billion...

N2:BIODRG N2:CMPNY N2:COMDIS N2:COVID N2:CPROD N2:DISEAS N2:GEN N2:HEA N2:HECA N2:HUMDIS N2:INFDIS N2:MEDREG N2:MRCH N2:NAMER N2:PHMR N2:PUBHEA N2:PUBL N2:US N2:VACCIN

US govt awards $1.4 billion for development of new COVID therapies, vaccines

(Reuters) – The U.S. government said on Tuesday it had awarded $1.4 billion for the...

N2:CMPNY N2:HEA N2:HECA N2:PHAG08 N2:PHAR1 N2:PUBL N2:TOPNWS N2:US

US FDA puts Gilead Sciences blood cancer drug studies on hold

(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical hold on...

N2:CMPNY N2:COVID N2:HEA N2:MRCH N2:MRCH1 N2:PUBHEA N2:PUBL N2:TOPNWS N2:US N2:VACCIN

Moderna’s updated COVID vaccine effective against ‘Eris’ variant in humans

(Reuters) – Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine...

N2:CMPNY N2:DIS N2:DISP N2:ENV N2:HEA N2:JOB N2:NAMER N2:POL N2:PUBL N2:RDRL N2:REGS N2:RRLF N2:RRLF1 N2:TOPNWS N2:US N2:USAOH N2:WASH

Norfolk Southern agrees to boost safety at Ohio derailment site, US says

By David Shepardson WASHINGTON (Reuters) – Norfolk Southern Corp has agreed to improve conditions for...

N2:BLR N2:CMPNY N2:CPROD N2:DRUDEV N2:HEA N2:HEADMI N2:HECA N2:MRCH N2:MTPIX N2:NAMER N2:PHAG08 N2:PHAR N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:RHEUMA N2:SCI N2:TOPNWS N2:US

AbbVie trims forecast for Humira sales drop on favorable coverage

By Leroy Leo and Patrick Wingrove (Reuters) -AbbVie on Thursday trimmed its 2023 view for...

N2:ADVO N2:AGRC N2:AGRC1 N2:AWLQ N2:BLR N2:CDIV08 N2:CHEM N2:CHEMDV N2:CMPNY N2:CONG N2:CONG08 N2:ENV N2:GEN N2:H2O N2:HEA N2:JUDIC N2:MTPIX N2:NAMER N2:NEWS1 N2:PUBL N2:PXP N2:TOPNWS N2:US N2:WATR

California, other states move to block 3M’s $10.3 billion PFAS deal

By Clark Mindock (Reuters) -A group of 22 states and U.S. territories on Wednesday moved...

N2:BLR N2:CMPNY N2:COVID N2:DRUGEN N2:HEA N2:HECA N2:MEDDTE N2:MEDQ N2:MEDQ1 N2:MRCH N2:MTPIX N2:NAMER N2:NEWS1 N2:PHAG08 N2:PHAR1 N2:PHMR N2:PUBL N2:PXP N2:RES N2:RESF N2:US N2:VACCIN

J&J upbeat on 2023 as devices rebound post-COVID, shares jump

By Bhanvi Satija and Patrick Wingrove (Reuters) -Johnson & Johnson on Thursday expressed optimism for...

N2:CMPNY N2:HEA N2:HOT N2:NAMER N2:PUBL N2:RCH N2:TCOM N2:TEEQ N2:TEL N2:TELNET N2:US N2:WIRTEL N2:WLES N2:WLES1

AT&T shares hit three-decade low as lead cables risk weighs

By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit...

N2:CMPNY N2:DEMENT N2:HEA N2:MEDCON N2:MEDREG N2:MRCH N2:MRCH1 N2:NAMER N2:PHMR N2:PUBL N2:SCI N2:US

Acumen’s Alzheimer’s drug passes initial safety test

By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...

Uncategorized

China pushes anti-‘bullying’ agenda amid tensions with US

Uncategorized

DOGE, CFPB disregarded court orders in mass firings, statement says

Uncategorized

Factbox-Citi raises three-month gold price target to $3,500 per ounce

Uncategorized

Trump administration kicks off plan for expanded offshore drilling